Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/20807Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Karachalios, G. | en |
| dc.contributor.author | Bablekos, G. | en |
| dc.contributor.author | Karachaliou, G. | en |
| dc.contributor.author | Charalabopoulos, A. K. | en |
| dc.contributor.author | Charalabopoulos, K. | en |
| dc.date.accessioned | 2015-11-24T19:10:15Z | - |
| dc.date.available | 2015-11-24T19:10:15Z | - |
| dc.identifier.issn | 0009-3157 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/20807 | - |
| dc.rights | Default Licence | - |
| dc.subject | Anti-Bacterial Agents/*therapeutic use | en |
| dc.subject | Anti-Infective Agents/*therapeutic use | en |
| dc.subject | Drug Therapy, Combination | en |
| dc.subject | Endocarditis, Bacterial/*drug therapy/microbiology/pathology | en |
| dc.subject | Humans | en |
| dc.subject | Male | en |
| dc.subject | Middle Aged | en |
| dc.subject | Netilmicin/*therapeutic use | en |
| dc.subject | Ofloxacin/*therapeutic use | en |
| dc.subject | Treatment Outcome | en |
| dc.subject | Yersinia Infections/*drug therapy/microbiology/pathology | en |
| dc.subject | Yersinia enterocolitica/*pathogenicity | en |
| dc.title | Infectious endocarditis due to Yersinia enterocolitica | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/12138334 | - |
| heal.identifier.secondary | http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000064923 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2002 | - |
| heal.abstract | Yersinia enterocolitica is a gram-negative coccobacillus. Y. enterocolitica infection is acquired by humans via the oral route. Infection due to Y. enterocolitica was first observed in 1933 in New York. Y. enterocolitica septicemia has been increasingly recognized in recent years, whereas endocarditis due to Y. enterocolitica is a rare manifestation. We herein describe a patient who developed Y. enterocolitica endocarditis and was successfully treated with a combination of drugs consisting of a quinolone (ofloxacin) and an aminoglycoside (netilmicin). | en |
| heal.journalName | Chemotherapy | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
